Saturday, September 26, 2020 2:12:25 PM
*Recent Highlights*
*Investor Presentation
https://ir.biocryst.com/static-files/c88e6cab-358f-4187-bac7-6384d8a73cf0
*Sept 8 - UFla researchers confirm Galidesivir promise vs COVID-19
https://ufhealth.org/news/2020/trio-medications-showing-early-promise-against-coronavirus-uf-health-researchers-find
*Sept 3 - US Govt buys RAPIVAB for strategic stockpile
https://ir.biocryst.com/node/21631/pdf
*Aug 31 - NIAID grants another $47 million for Galidesivir antiviral development
https://ir.biocryst.com/node/21596/pdf
*Aug 31 - FDA grants Orphan Drug status for oral Factor D inhibitor BCX9930
https://ir.biocryst.com/node/21581/pdf
*Aug 3- FDA grants Fast Track status for oral Factor D inhibitor BCX9930
https://ir.biocryst.com/node/21516/pdf
Recent BCRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 11:17:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 11:14:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 11:11:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 11:08:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2024 11:04:53 AM
- BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology • GlobeNewswire Inc. • 05/14/2024 11:00:53 AM
- ORLADEYO® (berotralstat) Approved in Mexico • GlobeNewswire Inc. • 05/13/2024 11:00:00 AM
- BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat) • GlobeNewswire Inc. • 05/09/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:02:30 PM
- BioCryst to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 11:00:22 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 11:03:00 AM
- BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/06/2024 11:00:00 AM
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 11:00:07 AM
- BioCryst to Report First Quarter 2024 Financial Results on May 6 • GlobeNewswire Inc. • 04/22/2024 11:00:50 AM
- BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency • GlobeNewswire Inc. • 04/17/2024 08:30:39 AM
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/03/2024 11:00:23 AM
- BioCryst to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 03/25/2024 08:01:00 PM
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/05/2024 12:01:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:25:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:32:01 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 02/27/2024 10:05:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:05:56 PM
- BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones • GlobeNewswire Inc. • 02/26/2024 12:00:05 PM
- U.S. Index Futures Dip Amid Inflation Data Anticipation, Oil and Iron Ore Prices Retreat • IH Market News • 02/26/2024 10:57:28 AM
- BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment • GlobeNewswire Inc. • 02/23/2024 12:00:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM